logo-loader
viewDiaMedica

DiaMedica adds stroke expert as vice president

DiaMedica (CVE:DMA) has added a stroke expert to its management structure.

Management.jpg
Dr Todd Verdoom will join as vice president of neuroscience.

DiaMedica (CVE:DMA) has added a stroke expert to its management structure.

Dr Todd Verdoom, who has 26 years’ worth of experience in the sector, including five with Bristol-Myers Squibb's stroke group, has joined as vice president of neuroscience.

Rick Pauls, president & chief executive of DiaMedica said: “His knowledge and experience in stroke will help DiaMedica as we focus our efforts on acute ischemic stroke."

Verdoorn said he is “very excited” about the prospects for DiaMedica’s lead compound, DM199, in neurological indications, particularly ischemic stroke.

Quick facts: DiaMedica

Price: 4.73 CAD

TSX-V:DMA
Market: TSX-V
Market Cap: $56.56 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Proactive Analyst Ryan Long talks global tin production

Proactive's Ryan Long takes a look at annual production levels and prospective tin operations at mines around the world. Ryan discusses the relative significance of the top three tin producing nations which are are China, Indonesia and Burma, accounting for over 70% of global tin production.

3 hours, 31 minutes ago

2 min read